FactaeThe Factual News

Valneva surges after regulatory milestone

Valneva's stock rose after a regulatory milestone on August 14.

Published 2h1 sourceNotable
Lire en français
≈ 13s

The fact

This step involves a vaccine or treatment under development.

Investors welcomed this validation for the biotech group.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
FranceWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 14, 2026
← Back to home
Discover

Read more

All marches →
marches12 %

Valneva surges following favorable stock market decision

3sem · 1 sourcemarches15 %

Valneva soars on US market after promising results

6sem · 1 sourcemarches

Valneva opens sharply higher on Wall Street ahead of quarterly results

2j · 1 sourcemarches

Valneva advances with new phase 3 trial for Lyme vaccine

16sem · 1 sourcemarches

Valneva awaited on regulatory filing for Lyme vaccine authorization

17sem · 1 sourcemarches

VALNEVA submits regulatory file to FDA for its vaccine

1sem · 1 source